News | Structural Heart | May 15, 2023

TVT 2023 Late-breaking Science Announced

CRF Meeting on Structural Heart Disease Innovations will take place June 7-10

CRF Meeting on Structural Heart Disease Innovations will take place June 7-10

May 15, 2023 — The Cardiovascular Research Foundation (CRF) announced that TVT: The Structural Heart Summit will feature 15 Late-Breaking Clinical Science studies. An annual meeting featuring cutting-edge research and techniques for structural heart interventions, TVT will take place June 7-10, 2023, at the Phoenix Convention Center – West in Phoenix, Arizona.

TVT has become the epicenter of innovation and collaboration in the structural heart arena over its 16-year history. The meeting brings together world-renowned experts and master operators to help translate novel discoveries into practical therapies for patients with valvular heart disease.

TVT’s late-breaking clinical science will highlight the latest advances in transcatheter aortic valve replacement as well as mitral, tricuspid, and left atrial appendage occlusion therapies. Data from these trials will help guide the selection of patients who will benefit most from these procedures and help define optimal treatment strategies, tools, and techniques for new and emerging treatments.

Thursday, June 8, 2023

Late-Breaking Clinical Science I

Mitral Valve Disease

Innovation & Clinical Science, Room 106

11:00 AM – 12:15 PM MST

  • Contemporary, Core-Lab Assessed, Acute Clinical Outcomes from 2000+ Patients with Mitral Regurgitation Treated with the 3rd and 4th Generation MitraClip Systems: Results from the EXPANDed Post Approval Studies
  • Longer-Term Clinical and Echocardiography Follow-up of Transcatheter Mitral Valve Replacement with the Trans-apical Intrepid System
  • Contemporary Outcomes of Transcatheter Transeptal Mitral Valve in Valve in the United States
  • Mitral Valve Repair versus Replacement after Transcatheter Edge-to-Edge Mitral Repair: Results from The CUTTING-EDGE Registry
  • Pressure Gradients and Mortality Following Transcatheter Mitral Valve in Valve and Valve in Ring

Friday, June 9, 2023

Late-Breaking Clinical Science II

Aortic Valve Disease (TAVR)

Innovation & Clinical Science, Room 106

11:00 AM – 12:15 PM MST

  • 5 Year Outcomes of TAVI Patients with Prosthesis-Patient Mismatc
  • Transcatheter Aortic Valve Replacement Using a Balloon-Expandable Valve in Patients with Type-0 Bicuspid Aortic Valve Stenosis
  • Real-World Early Outcomes of Evolut FX Versus PRO+ Transcatheter Aortic Valve Replacement
  • Analysis of New Permanent Pacemaker Implantation in the PORTICO NG Study Utilizing the Intra-Annular, Self-Expandable Navitor Transcatheter Aortic Heart Valve
  • Three-Year Outcomes from the Evolut Low Risk TAVR Bicuspid Study

Saturday, June 10, 2023

Late-Breaking Clinical Science III

Early Human Experiences – Mitral Valve Replacement Innovation

Innovation & Clinical Science, Room 106

  • Innovalve First-in-Human TMVR Experience (TWIST FIH): Clinical Outcomes and Echocardiography Evidence for Reverse Remodeling
  • Early Human Experience with the Cephea Transseptal TMVR System in Complex Mitral Anatomies
  • Bioprosthetic Surgical Valves in Intermediate-risk Patients: 1-Year Outcomes of the PARTNER 3 Mitral Valve-in-Valve Study
  • AltaValve Early Feasibility Study: Preservation of Mitral Valve Physiology Using a Passive Fixation TMVR Device
  • Trans-septal Mitral Valve Replacement with HighLife Valve in a Patient with Moderate-Severe Mitral Regurgitation

In addition to the 15 late-breaking science studies, TVT will feature:

  • More than 30 live cases from 13 leading academic medical centers in North America and Europe
  • Six tracks: Imaging, Left Atrial Appendage (LAA)/Patent Foramen Ovale (PFO), Heart Failure, Mitral, Tricuspid, and TAVR
  • Case-based sessions and hands-on training
  • Moderated poster presentations
  • And much more!

For more information: https://tvt2023.crfconnect.com/


Related Content

News | Cardiovascular Education

May 31, 2024 — In the United States there are over 8 million active athletes. Given the rapid expansion of sports ...

Home May 31, 2024
Home
News | Cardiovascular Education

April 25, 2024 —Heart-Valve-Surgery.com, a leading patient advocacy group for heart valve disease, with support from ...

Home April 25, 2024
Home
News | Cardiovascular Education

March 21, 2024 — The UCLA Department of Medicine has announced that Priscilla Hsue, MD will be joining as the chief of ...

Home March 21, 2024
Home
Feature | Cardiovascular Education | Christine Book

February 1, 2024 — As cardiologists, heart disease patients and the organizations that serve them across the country ...

Home February 01, 2024
Home
News | Cardiovascular Education

January 15, 2024 — A public-private partnership Think Tank, scheduled for Feb. 29-March 1, will be presented by the ...

Home January 15, 2024
Home
News | Cardiovascular Education

December 4, 2023 — The Minneapolis Heart Institute Foundation (MHIF), an internationally renowned cardiovascular ...

Home December 04, 2023
Home
News | Cardiovascular Education

October 5, 2023 — The 2023 American College of Cardiology (ACC) Quality Summit kicks off on October 11-13 in Orlando ...

Home October 05, 2023
Home
News | Cardiovascular Education

DAIC’s award-winning editorial team delivers industry trends and technology information to the professionals who make ...

Home August 16, 2023
Home
Feature | Cardiovascular Education | Christine Book

May 4, 2023 — A new book on a broad collection of cases, led by a team of investigators from the Smidt Heart Institute ...

Home May 04, 2023
Home
News | Cardiovascular Education

April 10, 2023 — Viatris Inc., a global healthcare company, and the American College of Cardiology (ACC) today released ...

Home April 10, 2023
Home
Subscribe Now